Dark

Check out our Dark Pool Levels

CVSI
CV SCIENCES INC
stock OTC

EOD

Aug 4, 2026

0.0259USD+36.316%(+0.0069)385,888

Pre-market

0.00USD-100.000%(-0.02)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 12, 2022

02:04PM EST Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More Benzinga

Jan 11, 2022

08:00AM EST CV Sciences, Inc. Announces Launch of +PlusCBD GlobeNewswire Inc

07:47AM EST CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients Benzinga

Jan 6, 2022

01:49PM EST Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US Benzinga

Jan 5, 2022

08:00AM EST CV Sciences, Inc. Announces New Distribution Agreement with GNC GlobeNewswire Inc

Dec 10, 2021

10:08AM EST Cantor Fitzgerald Maintains Neutral on CV Sciences, Lowers Price Target to $0.17 Benzinga

Nov 30, 2021

04:30PM EST CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has appointed Haskell & White LLP ("H&W") as the Company's new independent registered public accounting firm. GlobeNewswire Inc

Nov 15, 2021

05:00PM EST CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation Benzinga

08:25AM EST CV Sciences, Inc. Announces Convertible Note Financing GlobeNewswire Inc

08:05AM EST CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended September 30, 2021. GlobeNewswire Inc

Nov 12, 2021

11:03AM EST Earnings Preview For CV Sciences Benzinga

Nov 8, 2021

08:00AM EST CV Sciences, Inc. to Announce Third Quarter 2021 Results on GlobeNewswire Inc

Oct 15, 2021

12:18PM EDT EXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids Benzinga

Oct 7, 2021

01:02PM EDT CV Sciences, Inc. Applauds the California Legislature for Passage GlobeNewswire Inc

Oct 1, 2021

11:12AM EDT Looking Into CV Sciences's Return On Capital Employed Benzinga

Sep 20, 2021

10:43AM EDT Ryder Cup To Retirees: Many Golfers Say CBD Is A Hole In One For Their Game Benzinga

Aug 13, 2021

03:23PM EDT Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens Benzinga

02:45PM EDT Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization Benzinga

Aug 12, 2021

04:05PM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended June 30, 2021. GlobeNewswire Inc

Aug 2, 2021

12:45PM EDT American Cannabis Operator Index Lost 0.6% This Year, Best Players In July: Columbia Care, Lowell Farms, Ayr Wellness & Ascend Wellness Benzinga

Jul 23, 2021

08:12AM EDT Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21 Benzinga

Jul 22, 2021

01:30PM EDT CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences Benzinga

Jul 20, 2021

08:00AM EDT CV Sciences, Inc. and University of California, San Diego Publish GlobeNewswire Inc

Jul 10, 2021

08:44AM EDT Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021 Benzinga

Jul 9, 2021

10:31AM EDT Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour Benzinga

Jun 21, 2021

05:26PM EDT Cannabis Stock Gainers And Losers From June 21, 2021 Benzinga

Jun 18, 2021

12:10PM EDT Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences Benzinga

Jun 15, 2021

06:01PM EDT Cannabis Stock Gainers And Losers From June 15, 2021 Benzinga

May 27, 2021

05:17PM EDT Cannabis Stock Gainers And Losers From May 27, 2021 Benzinga

May 13, 2021

04:05PM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended March 31, 2021. GlobeNewswire Inc

May 12, 2021

05:09PM EDT Cannabis Stock Gainers And Losers From May 12, 2021 Benzinga

May 11, 2021

08:00AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of PlusCBD Calm and Sleep: two flavorful gummies that support healthy stress responses and sleep cycles for people getting back to their normal routines. GlobeNewswire Inc

May 6, 2021

07:00AM EDT CV Sciences, Inc. to Announce First Quarter 2021 Results on May GlobeNewswire Inc

Apr 13, 2021

08:30AM EDT CV Sciences and Alkemist Labs Form Partnership to Support the GlobeNewswire Inc

Mar 19, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 19, 2021 Benzinga

08:59AM EDT Roth Capital Maintains Neutral on CV Sciences, Lowers Price Target to $0.6 Benzinga

06:55AM EDT Piper Sandler Downgrades CV Sciences to Neutral, Announces $0.5 Price Target Benzinga

Mar 18, 2021

04:13PM EDT CV Sciences Q4 Sales $5.20M Miss $6.63M Estimate Benzinga

04:05PM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the year ended December 31, 2020. GlobeNewswire Inc

Mar 17, 2021

10:39AM EDT A Preview Of CV Sciences's Earnings Benzinga

Mar 10, 2021

07:00AM EST CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter GlobeNewswire Inc

Jan 29, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021 Benzinga

04:52AM EST Cantor Fitzgerald Downgrades CV Sciences to Neutral, Lowers Price Target to $0.65 Benzinga

Jan 5, 2021

08:30AM EST CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of ProCBD, a full product line of clinical strength CBD products available exclusively through health practitioners. GlobeNewswire Inc

Dec 22, 2020

04:44PM EST Cannabis Stock Gainers And Losers From December 22, 2020 Benzinga

Dec 10, 2020

10:45AM EST CV Sciences, Inc. Receives Nutritional Outlooks GlobeNewswire Inc

Dec 8, 2020

07:00AM EST CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it has entered into a Common Stock Purchase Agreement with Tumim Stone Capital, LLC (the Investor). GlobeNewswire Inc

Nov 4, 2020

07:00AM EST CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of PlusCBD Pet, a full line of hemp extracts formulated exclusively for dogs and cats. GlobeNewswire Inc

Oct 23, 2020

07:00AM EDT CV Sciences, Inc. to Announce Third Quarter 2020 Results on GlobeNewswire Inc

Oct 6, 2020

07:00AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced a comprehensive refresh of its top selling, flagship PlusCBD branded product line and the launch of 30+ new PlusCBD products over the next 45 days. GlobeNewswire Inc

Sep 10, 2020

08:45AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced its continued expansion into condition specific dietary supplements with the launch of CV Defense, the second of several products to be launched under its new Immunity product line, following the launch of CV Acute in August. GlobeNewswire Inc

Sep 2, 2020

08:45AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp-derived cannabidiol (CBD) products, is pleased to announce the launch of its new corporate website ( https://www.cvsciences.com/), reflecting the Companys refreshed brand positioning, core values and mission. GlobeNewswire Inc

Aug 20, 2020

08:00AM EDT CV Sciences, Inc. to Participate in Alliance Global Partners GlobeNewswire Inc

Aug 13, 2020

08:45AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp-derived cannabidiol (CBD) products, is pleased to announce the publication of two papers in the Journal of Dietary Supplements first Special Issue on Cannabinoids. GlobeNewswire Inc

Aug 6, 2020

05:13PM EDT CV Sciences Q2 EPS $(0.03), Inline, Sales $5.40M Miss $6.48M Estimate Benzinga

Aug 5, 2020

08:30PM EDT Cannabis Stock Gainers And Losers From August 5, 2020 Benzinga

08:45AM EDT CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of its new Happy Lane CBD product line. GlobeNewswire Inc

Jul 29, 2020

08:00AM EDT CV Sciences, Inc. Announces Expansion with the Launch of GlobeNewswire Inc

Jul 23, 2020

04:05PM EDT CV Sciences, Inc. to Announce Second Quarter 2020 Results on GlobeNewswire Inc

Share